Literature DB >> 9643514

Constructing a standard climacteric scale.

J G Greene1.   

Abstract

Issues relating to the design of scales and their psychometric properties are discussed in the context of constructing a standard measure of core climacteric symptoms. Seven factor analytic studies of climacteric symptoms are examined to determine whether or not there is sufficient consensus across studies to permit agreement on the symptom content and the structure of such a scale. It is argued that these factor analytic studies do indeed contain sufficient consensus on the basis of which a standard climacteric scale can be constructed. Such a scale is described.

Mesh:

Year:  1998        PMID: 9643514     DOI: 10.1016/s0378-5122(98)00025-5

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  72 in total

Review 1.  Effect of SERMs on the uterus and menopausal symptoms.

Authors:  M Dören
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

2.  Red clover isoflavones enriched with formononetin lower serum LDL cholesterol-a randomized, double-blind, placebo-controlled study.

Authors:  P B Clifton-Bligh; M-L Nery; R J Clifton-Bligh; S Visvalingam; G R Fulcher; K Byth; R Baber
Journal:  Eur J Clin Nutr       Date:  2014-11-05       Impact factor: 4.016

3.  Validation of POMS questionnaire in postmenopausal women.

Authors:  Kathleen W Wyrwich; Holly Yu
Journal:  Qual Life Res       Date:  2011-01-29       Impact factor: 4.147

4.  Predictors of psychological well-being and stress among Jordanian menopausal women.

Authors:  Rania Y Abdelrahman; Lubna A Abushaikha; Mohammad A al-Motlaq
Journal:  Qual Life Res       Date:  2013-06-28       Impact factor: 4.147

Review 5.  Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early postmenopause: a systematic review.

Authors:  Annette J Thomas; Rita Ismail; Lisa Taylor-Swanson; Lori Cray; Janet G Schnall; Ellen Sullivan Mitchell; Nancy Fugate Woods
Journal:  Maturitas       Date:  2014-05-28       Impact factor: 4.342

6.  Safety and feasibility of estrogen receptor-β targeted phytoSERM formulation for menopausal symptoms: phase 1b/2a randomized clinical trial.

Authors:  Lon S Schneider; Gerson Hernandez; Liqin Zhao; Adrian A Franke; Yu-Ling Chen; Sonia Pawluczyk; Wendy J Mack; Roberta D Brinton
Journal:  Menopause       Date:  2019-08       Impact factor: 2.953

7.  Ramelteon for the treatment of insomnia in menopausal women.

Authors:  Roseanne DeFronzo Dobkin; Matthew Menza; Karina L Bienfait; Lesley A Allen; Humberto Marin; Michael A Gara
Journal:  Menopause Int       Date:  2009-03

8.  Objective hot flashes are negatively related to verbal memory performance in midlife women.

Authors:  Pauline M Maki; Lauren L Drogos; Leah H Rubin; Suzanne Banuvar; Lee P Shulman; Stacie E Geller
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

9.  Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial.

Authors:  Stacie E Geller; Lee P Shulman; Richard B van Breemen; Suzanne Banuvar; Ying Zhou; Geena Epstein; Samad Hedayat; Dejan Nikolic; Elizabeth C Krause; Colleen E Piersen; Judy L Bolton; Guido F Pauli; Norman R Farnsworth
Journal:  Menopause       Date:  2009 Nov-Dec       Impact factor: 2.953

10.  Menopause status and attitudes in a Turkish midlife female population: an epidemiological study.

Authors:  Unal Ayranci; Ozgul Orsal; Ozlem Orsal; Gul Arslan; Dursun Figen Emeksiz
Journal:  BMC Womens Health       Date:  2010-01-11       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.